Sydney Mason Weaver
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 143 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AbbVie at 37.7% of the total. Reporting peaked in 2023 at $1,581 and has fallen 97.5% since, to $40 in 2025.
Across 143 payments — averaging $19.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Sanofi$259
- Bristol Myers Squibb$256
- Gilead$161
- Intercept Pharmaceuticals, Inc.$152
- Johnson & Johnson$150
- plus $794 from 23 others
What the payments were for
- Food & beverage$2,78698%
- Education$572%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 59 | $1,071 |
| Sanofi | 9 | $259 |
| Bristol Myers Squibb | 19 | $256 |
| Gilead | 6 | $161 |
| Intercept Pharmaceuticals, Inc. | 7 | $152 |
| Johnson & Johnson(2 entities) | 6 | $150 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $100 |
| Regeneron Healthcare Solutions, Inc. | 3 | $81 |
| Abbott | 1 | $53 |
| Ardelyx, Inc. | 3 | $52 |
| Redhill Biopharma Inc. | 2 | $43 |
| Ipsen Biopharmaceuticals, Inc | 2 | $43 |
| Pfizer | 2 | $36 |
| Mirum Pharmaceuticals, Inc. | 1 | $35 |
| Eisai Inc. | 1 | $23 |
| Fresenius Kabi USA, LLC | 1 | $21 |
| Boehringer Ingelheim | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Braintree Laboratories, Inc. | 1 | $18 |
| AstraZeneca | 1 | $18 |
| Merck | 1 | $18 |
| Biogen | 1 | $18 |
| Sandoz | 1 | $16 |
| Exact Sciences | 1 | $15 |
| Hologic Sales And Service, LLC | 1 | $15 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Vistapharm, Inc. | 1 | $12 |
How this compares
$2,843 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Famotidine | 21 | $459 |
| Pantoprazole Sodium | 27 | $211 |
Paid to pharmacies, not to this prescriber.
Other family in Tampa
- Lewis HarringtonTampa$954K
- Marie Labadie-DegennaroTampa$66K
- Polly BittleTampa$63K
- Katharine WilliamsTampa$47K
- Candace DeberryTampa$46K
- Bailey BlankenshipTampa$42K
- Rasheeta ChandlerTampa$37K
- Rosaly TorresTampa$28K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.